Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel Disease

Nanja Bevers1, Els Van de Vijver2, Adrienne Hanssen3

  • 1From the Department of Pediatrics, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.

Insights

Children with inflammatory bowel disease (IBD) experiencing fatigue showed reduced moderate-to-vigorous physical activity. Standard biological markers did not differentiate fatigued from non-fatigued pediatric IBD patients.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Outcomes in Chronic Illness

Background:

  • Fatigue is a prevalent symptom in pediatric patients diagnosed with inflammatory bowel disease (IBD).
  • Current diagnostic approaches for fatigue in pediatric IBD primarily focus on biological markers like inflammation and hemoglobin levels.
  • Functional parameters assessing physical activity and daily functioning remain understudied in this population.

Purpose of the Study:

  • To compare fatigued and non-fatigued pediatric IBD patients using both biological and functional assessments.
  • To identify key differences in biological markers and physical activity levels between fatigued and non-fatigued children with IBD.
  • To explore potential new methods for distinguishing fatigued from non-fatigued pediatric IBD patients.

Main Methods:

  • A cross-sectional study involving 104 pediatric IBD patients with mild to moderate disease activity.
  • Fatigue was defined using the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (z score <-2.0).
  • Evaluated disease-specific quality of life (IMPACT-III), C-reactive protein (CRP), fecal calprotectin (FC), hemoglobin z score (Hb z score), 6-minute walking distance (6MWD z score), and triaxial accelerometry (TA).

Main Results:

  • Fatigued children (n=24) reported significantly lower disease-specific quality of life (IMPACT-III) compared to non-fatigued children (n=80).
  • No significant differences were observed in Hb z scores, CRP, FC, or 6MWD z scores between the groups.
  • Triaxial accelerometry (TA) revealed that fatigued patients spent significantly less time in moderate-to-vigorous physical activity (18.3 min/day) compared to non-fatigued patients (37.3 min/day).

Conclusions:

  • Standard biological markers are insufficient to differentiate fatigued from non-fatigued pediatric IBD patients.
  • Triaxial accelerometry (TA) shows promise in distinguishing fatigued from non-fatigued individuals.
  • Functional assessment of physical activity may offer a valuable target for interventions aimed at improving quality of life in pediatric IBD patients experiencing fatigue.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
356
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
296
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
219
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
486
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
154
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195